From Decoupling To Delisting: Might Biden-Xi Talks Ease Biotech Overhang?

While a two-hour-plus online discussion between the leaders of the world's two largest economies had some encouraging signs for the biopharma sector, more remains to be done and multiple other factors are playing into a mix of decoupling pressures.

BILATERAL AGREEMENT NEEDED TO RESOLVE US-LISTED CHINESE BIOTECHS' DELISTING OVERHANG • Source: Shutterstock

Many have been waiting for some reassurance from the highly-anticipated bilateral discussions between US President Joe Biden and Chinese President Xi Jinping, amid tensions between the world's two largest economies that has reached an all-time high.

During a virtual discussion between the two leaders held on 28 July that lasted for two hours and 20 minutes,...

More from China

More from Focus On Asia